Robert Ortenzio | Co-Founder & Executive Chairman |
Martin Jackson | EVP & CFO |
Frank Morgan | RBC Capital Markets |
Peter Costa | Wells Fargo Securities |
Kevin Fischbeck | Bank of America Merrill Lynch |
Albert J. Rice | Crédit Suisse |
William Sutherland | The Benchmark Company |
Good morning, and thank you for joining us today for Select Medical Holdings Corporation's earnings conference call to discuss the second quarter 2019 results and the company's business outlook.
Speaking today are company's Executive Chairman and Co-founder, Robert Ortenzio; and the company's Executive Vice President and Chief Financial Officer, Martin Jackson. Management will give you an overview of the quarter and then open the call for questions.
Before we get started, we would like to remind you that this conference call may contain forward-looking statements regarding future events or future financial performance of the company, including, without limitation, statements regarding operating results, growth opportunities and other statements that refer to Select Medical's plans, expectations, strategies, intentions and beliefs.
These forward-looking statements are based on the information available to management of Select Medical today, and the company assumes no obligation to update these statements as circumstances change.